Respiratory infections cause the release of extracellular vesicles: Implications in exacerbation of asthma/COPD

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Eltom, Suffwan ^a   Dale, Nicole ^a   Raemdonck, Kristof R G ^a   Stevenson, Christopher S ^b,e   Snelgrove, Robert J ^a   Sacitharan, Pradeep K ^a   Recchi, Chiara ^a   Wavre Shapton, Silene ^c   McAuley, Daniel F ^d   O'Kane, Cecilia ^d   Belvisi, Maria G ^a   Birrell, Mark A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NOVARTIS   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e Respivert   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[5 (2,3 DICHLOROPHENYL) 1H TETRAZOL 1 YL]METHYL]PYRIDINE; ADENOSINE TRIPHOSPHATE; AZ 11645373; CASPASE; INTERLEUKIN 18; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL ORGANELLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; DRUG EFFECT; EX VIVO STUDY; EXTRACELLULAR VESICLE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; ANIMAL; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; MEMBRANE MICROPARTICLE; METABOLISM; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASTHMA; CASPASES; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; HUMANS; INTERLEUKIN-18; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, PURINERGIC P2X7; RESPIRATORY TRACT INFECTIONS;

EID: 84903397339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101087     Document Type: Article

References (43)

1. Masoli M, Fabian D, Holt S, Beasley R, Program GI for A (GINA) (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478. (Pubitemid 38580764)
2. Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765-773. (Pubitemid 47321908)
3. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, et al. (2007) Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 62: 758-766.
4. Barnes PJ (2008) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192.
5. Organisation WH (2007) World Health Organisation. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach.: ISBN 978 92 4; 12-36.
6. Jackson DJ, Sykes A, Mallia P, Johnston SL (2011) Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 128: 1165-1174.
7. O'Byrne PM (2009) Allergen-induced airway inflammation and its therapeutic intervention. Allergy Asthma Immunol Res 1: 3-9.
8. Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370: 786-796. (Pubitemid 47320802)
9. Pauwels RA (2004) Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 1: 73-76.
10. Schwenkglenks M, Lowy A, Anderhub H, Szucs TD (2003) Costs of asthma in a cohort of Swiss adults: associations with exacerbation status and severity. Value Health 6: 75-83. (Pubitemid 36228351)
11. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW (2009) Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 179: 19-24.
12. Botelho FM, Bauer CMT, Finch D, Nikota JK, Zavitz CCJ, et al. (2011) IL-1α/IL-1R1 Expression in Chronic Obstructive Pulmonary Disease and Mechanistic Relevance to Smoke-Induced Neutrophilia in Mice. PLoS One 6: e28457-e28457.
13. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, et al. (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 184: 662-671.
14. Kersul AL, Iglesias A, Ríos Á, Noguera A, Forteza A, et al. (2011) Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 47: 176-183.
15. Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Millares L, et al. (2012) Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD 9: 121-130.
16. Gessner C, Scheibe R, Wötzel M, Hammerschmidt S, Kuhn H, et al. (2005) Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med 99: 1229-1240. (Pubitemid 41245308)
17. Van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R (2012) Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64: 676-705.
18. György B, Szabó TG, Pásztói M, Pál Z, Misják P, et al. (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68: 2667-2688.
19. Robbins PD, Morelli AE (2014) Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14: 195-208.
20. Gulinelli S, Salaro E, Vuerich M, Bozzato D, Pizzirani C, et al. (2012) IL-18 associates to microvesicles shed from human macrophages by a LPS/TLR-4 independentmechanism in response to P2X receptor stimulation. Eur J Immunol: 1-38.
21. Pizzirani C, Ferrari D, Chiozzi P, Adinolfi E, Sandonà D, et al. (2007) Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109: 3856-3864. (Pubitemid 46641737)
22. Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179: 1913-1925.
23. Sarkar A, Mitra S, Wewers MD (2009) Release of caspase-1 and IL-1beta in microvesicles regulated by ATP ion channels. Poster Sess Present Annu Res Day, Div Pulm Allergy, Crit care Sleep Med.
24. Polosa R, Blackburn MR (2006) Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci 30: 528-535.
25. Mohsenin A, Blackburn MR (2006) Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 12: 54-59. (Pubitemid 44378579)
26. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MAM, et al. (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13: 913-919. (Pubitemid 47222044)
27. Lommatzsch M, Cicko S, Müller T, Lucattelli M, Bratke K, et al. (2010) Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181: 928-934.
28. Eltom S, Stevenson CS, Rastrick J, Dale N, Raemdonck K, et al. (2011) P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One 6: e24097-e24097.
29. Eltom S, Stevenson C, Birrell MA (2013) Cigarette Smoke Exposure as a Model of Inflammation Associated with COPD. Curr Protoc Pharmacol: 14.24.1-14.24.1.
30. Haddad EB, Birrell M, McCluskie K, Ling A, Webber SE, et al. (2001) Role of p38 MAP kinase in LPS-induced airway inflammation in the rat. Br J Pharmacol 132: 1715-1724. (Pubitemid 32397963)
31. Birrell M a, Battram CH, Woodman P, McCluskie K, Belvisi MG (2003) Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways. Respir Res 4: 3.
32. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJP, et al. (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 7: 780-788.
33. Soo CY, Song Y, Zheng Y, Campbell EC, Riches AC, et al. (2012) Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 136: 192-197.
34. Shyamsundar M, McKeown STW, O'Kane CM, Craig TR, Brown V, et al. (2009) Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 179: 1107-1114.
35. Harris P, Sridhar S, Peng R, Phillips JE, Cohn RG, et al. (2013) Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPD. Mucosal Immunol 6: 474-484.
36. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, et al. (2000) Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 165: 3934-3940. (Pubitemid 32057302)
37. Hardaker EL, Freeman MS, Dale N, Bahra P, Raza F, et al. (2010) Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung. Br J Pharmacol 160: 1985-1996.
38. De Kluijver J, Grünberg K, Pons D, de Klerk EP, Dick CR, et al. (2003) Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects. Clin Exp Allergy 33: 1415-1418. (Pubitemid 37289939)
39. Qu Y, Ramachandra L, Mohr S, Franchi L, Harding C V, et al. (2009) P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol 182: 5052-5062.
40. Wang J-G, Williams JC, Davis BK, Jacobson K, Doerschuk CM, et al. (2011) Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood 118: 2366-2374.
41. Lucattelli M, Cicko S, Müller T, Lommatzsch M, De Cunto G, et al. (2011) P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am J Respir Cell Mol Biol 44: 423-429.
42. Cicko S, Lucattelli M, Müller T, Lommatzsch M, De Cunto G, et al. (2010) Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol 185: 688-697.
43. Monção-Ribeiro LC, Cagido VR, Lima-Murad G, Santana PT, Riva DR, et al. (2011) Lipopolysaccharide-induced lung injury: role of P2X7 receptor. Respir Physiol Neurobiol 179: 314-325.